Role of drug-eluting balloons in dialysis access interventions

Peiman Habibollahi; Girish Kumar; Dianbo Zhang; Harold Park

doi:10.1007/978-3-030-52994-9_19

Role of drug-eluting balloons in dialysis access interventions

Peiman Habibollahi, Girish Kumar, Dianbo Zhang, Harold Park

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Balloon angioplasty is a well-established treatment option in the maintenance of dialysis accesses. Angioplasty is typically performed when there is a stenosis of 50% or greater on either fluoroscopic or sonographic studies. Successful treatment is represented by a residual stenosis of less than 30%. Several drug-coated balloons (DCBs), first used in arterial peripheral vascular disease, have recently been employed to improve the patency of dialysis accesses after angioplasty. The objective of including these balloons is to prolong the time between interventions.

Original language	English (US)
Title of host publication	Dialysis Access Management
Subtitle of host publication	Second Edition
Publisher	Springer International Publishing
Pages	283-291
Number of pages	9
ISBN (Electronic)	9783030529949
ISBN (Print)	9783030529932
DOIs	https://doi.org/10.1007/978-3-030-52994-9_19
State	Published - Jan 20 2021

Keywords

Angioplasty
Arteriovenous fistula
Dialysis access
Paclitaxel drug-eluting balloon

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-52994-9_19

Cite this

@inbook{01df74b9a4c6464da3f3073df08d6070,

title = "Role of drug-eluting balloons in dialysis access interventions",

abstract = "Balloon angioplasty is a well-established treatment option in the maintenance of dialysis accesses. Angioplasty is typically performed when there is a stenosis of 50% or greater on either fluoroscopic or sonographic studies. Successful treatment is represented by a residual stenosis of less than 30%. Several drug-coated balloons (DCBs), first used in arterial peripheral vascular disease, have recently been employed to improve the patency of dialysis accesses after angioplasty. The objective of including these balloons is to prolong the time between interventions.",

keywords = "Angioplasty, Arteriovenous fistula, Dialysis access, Paclitaxel drug-eluting balloon",

author = "Peiman Habibollahi and Girish Kumar and Dianbo Zhang and Harold Park",

year = "2021",

month = jan,

day = "20",

doi = "10.1007/978-3-030-52994-9_19",

language = "English (US)",

isbn = "9783030529932",

pages = "283--291",

booktitle = "Dialysis Access Management",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Role of drug-eluting balloons in dialysis access interventions

AU - Habibollahi, Peiman

AU - Kumar, Girish

AU - Zhang, Dianbo

AU - Park, Harold

PY - 2021/1/20

Y1 - 2021/1/20

N2 - Balloon angioplasty is a well-established treatment option in the maintenance of dialysis accesses. Angioplasty is typically performed when there is a stenosis of 50% or greater on either fluoroscopic or sonographic studies. Successful treatment is represented by a residual stenosis of less than 30%. Several drug-coated balloons (DCBs), first used in arterial peripheral vascular disease, have recently been employed to improve the patency of dialysis accesses after angioplasty. The objective of including these balloons is to prolong the time between interventions.

AB - Balloon angioplasty is a well-established treatment option in the maintenance of dialysis accesses. Angioplasty is typically performed when there is a stenosis of 50% or greater on either fluoroscopic or sonographic studies. Successful treatment is represented by a residual stenosis of less than 30%. Several drug-coated balloons (DCBs), first used in arterial peripheral vascular disease, have recently been employed to improve the patency of dialysis accesses after angioplasty. The objective of including these balloons is to prolong the time between interventions.

KW - Angioplasty

KW - Arteriovenous fistula

KW - Dialysis access

KW - Paclitaxel drug-eluting balloon

UR - http://www.scopus.com/inward/record.url?scp=85148548856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148548856&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-52994-9_19

DO - 10.1007/978-3-030-52994-9_19

M3 - Chapter

AN - SCOPUS:85148548856

SN - 9783030529932

SP - 283

EP - 291

BT - Dialysis Access Management

PB - Springer International Publishing

ER -

Role of drug-eluting balloons in dialysis access interventions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this